The action establishes belzutifan as the only approved oral therapy for PPGL. The approval stipulates use in adults and ...

The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL ...

(WASHINGTON) — The U.S. Food and Drug Administration (FDA) approved on Friday additional ... artificial food dyes. The agency approved two dyes and expanded approval of a third, meaning it ...